Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults
No immune interference was observed when PCV13 and MF59-aTIV were given together. The immunogenicity criteria of influenza vaccine was met irrespective of concomitant vaccination. Concomitant vaccination showed good safety profiles.